The DOI matches its Crossref record, with a small difference in title or year; 171 of the 172 references it cites were found in a registry or an index.
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
Open accessAbstract
Nonischemic dilated cardiomyopathy (DCM) often has a genetic pathogenesis. Because of the large number of genes and alleles attributed to DCM, comprehensive genetic testing encompasses ever-increasing gene panels. Genetic diagnosis can help predict prognosis, especially with regard to arrhythmia risk for certain subtypes. Moreover, cascade genetic testing in family members can identify those who are at risk or with early stage disease, offering the opportunity for early intervention. This review will address diagnosis and management of DCM, including the role of genetic evaluation. We will also overview distinct genetic pathways linked to DCM and their pathogenetic mechanisms. Historically, cardiac morphology has been used to classify cardiomyopathy subtypes. Determining genetic variants is emerging as an additional adjunct to help further refine subtypes of DCM, especially where arrhythmia risk is increased, and ultimately contribute to clinical management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dilated cardiomyopathy (DCM) is defined by an enlarged and poorly contractile LV. Genetic or non-genetic causes, including hypertension and valve diseases, may lead to dilated cardiomyopathy. This type of heart disease is the major cause of HF [51,53].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Contemporary Definitions and Classification of the Cardiomyopathies
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,715
Authors Task Force Members, Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, J. A., Elliot, P. M., Fitzsimons, D., Hatala, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv319 · Cited by 1,671
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Self-citation
Research works printed but not linked: 2
- 10.1172/JCI19670 · DOI
- MacRae C, Taylor MRG, Mestroni L, Moses JR, Ashley EA, Wheeler MT, Lakdawala NK, Hershberger RE, Ptaszynski M, Sandor V, Saunders ME, Oliver C, Lee PA, Judge DP. Phase 2 study of a797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin a/c-related dilated cardiomyopathy. Eur Heart J. 2016;37:1011.
Cited by
Sorted by citations
Items 301–400 of 791
Cleary, S. R., Teng, A. C. T., Kongmeneck, A. D., Fang, X., Phillips, T. A., Cho, E. E., Smith, R. A., Karkut, P., Makarewich, C. A., Kekenes-Huskey, P. M., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108118 · Cited by 14
Angelini, A., Gorey, M.-A., Dumont, F., Mougenot, N., Chatzifrangkeskou, M., Muchir, A., Li, Z., Mericskay, M., & Decaux, J. (2019) · The FASEB Journal · doi:10.1096/fj.201902389r · Cited by 13
Integrative network analysis interweaves the missing links in cardiomyopathy diseasome
Chauhan, P. K., & Sowdhamini, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-24246-x · Cited by 12
Quality of life and societal costs in patients with dilated cardiomyopathy
Wiethoff, I., Sikking, M. A., Evers, S., Gabrio, A., Henkens, M. T. H. M., Michels, M., Verdonschot, J. A. J., Heymans, S. R. B., & Hiligsmann, M. (2023) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcad056 · Cited by 12
Assessing Cardiac Contractility From Single Molecules to Whole Hearts
Garg, A., Lavine, K. J., & Greenberg, M. J. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.07.013 · Cited by 12
The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on the ‘Forgotten’ Right Ventricle
Qu, L., Duan, X., & Chen, H. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15103 · Cited by 12
Pitfalls in performing genome-wide association studies on ratio traits
McCaw, Z. R., Dey, R., Somineni, H., Amar, D., Mukherjee, S., Sandor, K. P., Karaletsos, T., Koller, D., Aschard, H., Smith, G. D., et al. (2025) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2025.100406 · Cited by 14
Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy–Related Cardiomyopathies
Maamari, D. J., Biddinger, K. J., Jurgens, S. J., Rämö, J. T., Gaziano, L., Zheng, A., Challa, S. P., Hayes, D., Gongora, C. A., Choi, S. H., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.3248 · Cited by 12
Roman, A., Zimmer, A., Gotthardt, M., Steinmetz, L. M., Kühn, R., & Dang, T. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102734 · Cited by 12
Molecular characterization of Portuguese patients with dilated cardiomyopathy
Sousa, A., Canedo, P., Azevedo, O. M., Lopes, L. R., Pinho, T., Baixia, M., Rocha‐Gonçalves, F., Gonçalves, L. M. M., Silva‐Cardoso, J., Machado, J. C., et al. (2019) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repc.2018.10.010 · Cited by 13
Jordà, P., Toro, R., Díez‐López, C., Salazar‐Mendiguchía, J., Fernández-Falgueras, A., Pérez‐Serra, A., Coll, M., Puigmulé, M., Arbelo, E., García‐Álvarez, A., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020130 · Cited by 12
Xu, H., Wali, R., Cheruiyot, C., Bodenschatz, J. F. E., Hasenfuss, G. P., Janshoff, A., Habeck, M., & Ebert, A. (2021) · FEBS Letters · doi:10.1002/1873-3468.14189 · Cited by 13
Dilated Cardiomyopathy Associated with Paraquat Herbicide Poisoning
Ahmad, J., D’Angelo, K., Rivas, M., Mahal, M., Nookala, V., Kulakauskiene, D., & Makaryus, A. N. (2021) · Clinics and Practice · doi:10.3390/clinpract11030083 · Cited by 12
Familial Risk of Dilated and Hypertrophic Cardiomyopathy: A National Family Study in Sweden
Ricci, F., Banihashemi, B., Pirouzifard, M., Sundquist, J., Sundquist, K., Sutton, R., Fedorowski, A., & Zöller, B. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14171 · Cited by 12
Lennermann, D. C., Pepin, M. E., Grosch, M., Konrad, L., Kemmling, E., Hartmann, J., Nolte, J. L., Clauder‐Münster, S., Kayvanpour, E., Sedaghat‐Hamedani, F., et al. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00328.2022 · Cited by 12
Nicotinamide riboside kinase-2 regulates metabolic adaptation in the ischemic heart
Marzook, H., Gupta, A., Tomar, D., Saleh, M. A., Patil, K., Semreen, M. H., Hamoudi, R., Soares, N. C., Qaisar, R., & Ahmad, F. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02296-6 · Cited by 12
Ameri, P., Schiattarella, G. G., Crotti, L., Torchio, M., Bertero, E., Rodolico, D., Forte, M., Mauro, V. D., Paolillo, R., Chimenti, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041192 · Cited by 12
Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controls
Andersson, C., Schou, M., Schwartz, B., Vasan, R. S., Christiansen, M. N., D’Souza, M., Weeke, P. E., Køber, L., Christensen, A. H., Gislason, G., et al. (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.101065 · Cited by 13
Gene Editing Applications as Future Cardiovascular Therapies
Tadokoro, T., Olson, E. N., & Liu, N. (2025) · Annual Review of Genetics · doi:10.1146/annurev-genet-011725-094039 · Cited by 11
Hu, M., Liu, P., Lu, S., Wang, Z., Lyu, Z., Liu, H., Sun, Y., Liu, F., & Tian, J. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00532-0 · Cited by 11
Myers, M. C., Wang, S., Zhong, Y., Maruyama, S., Bueno, C., Bastien, A., Fazeli, M. S., & Golchin, N. (2024) · Cardiology Research · doi:10.14740/cr1680 · Cited by 11
Barrick, S. K., Greenberg, L., & Greenberg, M. J. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e21-02-0082 · Cited by 12
Bidzimou, M.-T. K., & Landstrom, A. P. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101978 · Cited by 11
Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives
Ferro, M. D., Severini, G. M., Gigli, M., Mestroni, L., & Sinagra, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-13864-6_5 · Cited by 12
Self-citationQiao, Q., Zhao, C., Yang, C., Gu, J.-N., Guo, Y., Zhang, M., Li, R., Qiu, X., Xu, Y., & Yang, Y. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1318 · Cited by 11
Circular RNAs: New Players in Cardiomyopathy
Moghaddam, M. B., Maleki, M., Oveisee, M., Moghaddam, M. B., Arabian, M., & Malakootian, M. (2022) · Genes · doi:10.3390/genes13091537 · Cited by 11
Extracellular vesicles in cardiomyopathies: A narrative review
Rizzuto, A. S., Faggiano, A., Macchi, C., Carugo, S., Perrino, C., & Ruscica, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23765 · Cited by 10
Du, Z., Zhou, Y., Li, Q., Xie, Y., Zhu, T., Qiao, J., Zhang, R., Bao, Y., Wang, L., Xie, Y., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.05.011 · Cited by 11
Wu, X., Lee, Y.-K., Lau, Y., Au, K., Tse, Y.-L., Ng, K., Wong, C., & Tse, H. (2024) · Pharmaceuticals · doi:10.3390/ph17081030 · Cited by 9
Kubánek, M., Bínová, J., Piherová, L., Krebsová, A., Kotrč, M., Hartmannová, H., Hodaňová, K., Mušálková, D., Stránecký, V., Paleček, T., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15009 · Cited by 10
Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review
Micolonghi, C., Perrone, F., Fabiani, M., Caroselli, S., Savio, C., Pizzuti, A., Germani, A., Visco, V., Petrucci, S., Rubattu, S. D., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189787 · Cited by 10
Regulatory mechanisms of m6A methylation in dilated cardiomyopathy
Zhang, H. (2025) · American Journal of Translational Research · doi:10.62347/aosk8903 · Cited by 10
Biophysical Derangements in Genetic Cardiomyopathies
Lynn, M. L., Lehman, S. J., & Tardiff, J. C. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.12.002 · Cited by 10
Karvonen, V., Harjama, L., Heliö, K., Kettunen, K., Elomaa, O., Koskenvuo, J. W., Kere, J., Weckström, S., Holmström, M., Saarela, J., et al. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18164 · Cited by 10
Knockout mice are an important tool for human monogenic heart disease studies
Cacheiro, P., Spielmann, N., Mashhadi, H. H., Fuchs, H., Gailus‐Durner, V., Smedley, D. P., & de Angelis, M. H. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049770 · Cited by 10
Multimodality imaging predictors of sudden cardiac death
Bandera, F., Baghdasaryan, L., Mandoli, G. E., & Cameli, M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09893-z · Cited by 10
Fousse, S. L., Tyrrell, W. D., Dentino, M. E., Abrams, F. L., Rosenthal, S. L., & Stern, J. A. (2019) · Canine Genetics and Epidemiology · doi:10.1186/s40575-019-0079-y · Cited by 11
Anderson, J. L., Christensen, G. B., Escobar, H., Horne, B. D., Knight, S., Jacobs, V., Afshar, K., Hebl, V. B., Muhlestein, J. B., Knowlton, K. U., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.09.026 · Cited by 10
Modern genomic techniques in the identification of genetic causes of cardiomyopathy
Spracklen, T. F., Keavney, B. D., Laing, N., Ntusi, N., & Shaboodien, G. (2022) · Heart · doi:10.1136/heartjnl-2021-320424 · Cited by 10
Fang, C., Lv, Z., Yu, Z., Wang, K., Xu, C., Li, Y., & Wang, Y. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02759-7 · Cited by 10
Research landscape of genetics in dilated cardiomyopathy: insight from a bibliometric analysis
Chao, T., Sun, J., Ge, Y., & Wang, C. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1362551 · Cited by 9
Contribution of Increased Expression of Yin Yang 2 to Development of Cardiomyopathy
Zhang, Y., Beketaev, I., Segura, A. M., Yu, W., Xi, Y. T., Chang, J., Ma, Y., & Wang, J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00035 · Cited by 9
Pourebrahim, K., Marian, J. G., Tan, Y., Chang, J. T., & Marian, A. J. (2021) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.15 · Cited by 10
Multi-omics assessment of dilated cardiomyopathy using non-negative matrix factorization
Tappu, R., Haas, J., Lehmann, D. H., Sedaghat‐Hamedani, F., Kayvanpour, E., Keller, A., Katus, H. A., Frey, N., & Meder, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272093 · Cited by 9
Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
Vicent, L., Garcia, J. A., Vázquez, R., González‐Juanatey, J. R., Rivera, M., Segovia, J., Pascual-Figal, D. A., Bover, R., Worner, F., Fernández‐Avilés, F., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12083028 · Cited by 9
Zhong, G., Chen, C., Wu, S., Chen, J., Han, Y., Zhu, Q., Xu, M., Nie, Q., & Wang, L. (2023) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-23-112 · Cited by 9
Utilities and Limitations of Cardiac Magnetic Resonance Imaging in Dilated Cardiomyopathy
Cha, M. J., Hong, Y. J., Park, C. H., Cha, Y. J., Kim, C., Kim, C., & Park, C. H. (2023) · Korean Journal of Radiology · doi:10.3348/kjr.2023.0531 · Cited by 9
Hu, Y., Zou, Y., Qiao, L., & Lin, L. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.08.030 · Cited by 9
New insights provided by myofibril mechanics in inherited cardiomyopathies.
Lin, Y., Yap, J. J. L., Ramachandra, C. J. A., & Hausenloy, D. J. (2019) · PubMed · Cited by 9
Lavine, K. J., & Greenberg, M. J. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10021-5 · Cited by 9
The genetics of left ventricular noncompaction
Cannie, D. E., & Elliot, P. M. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000844 · Cited by 9
Diagnosis of Cardiac Abnormalities in Muscular Dystrophies
Bădilă, E., Lungu, I. I., Grumezescu, A. M., & Scafa‐Udriște, A. (2021) · Medicina · doi:10.3390/medicina57050488 · Cited by 9
Barndt, R. J., Ma, N., Tang, Y. M., Haugh, M. P., Alamri, L. S., Chan, S. Y., & Wu, H. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102544 · Cited by 9
CASZ1: Current Implications in Cardiovascular Diseases and Cancers
Jian, H., & Poetsch, A. (2023) · Biomedicines · doi:10.3390/biomedicines11072079 · Cited by 9
Genetic Spectrum of Arrhythmogenic Cardiomyopathy
Gacita, A. M., & McNally, E. M. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.005850 · Cited by 10
Self-citationDufour, C. R., Xia, H., B'Chir, W., Perry, M.-C., Kuzmanov, U., Gainullina, A., Dejgaard, K., Scholtes, C., Ouellet, C., Zuo, D., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03942-4 · Cited by 8
Risk stratification in patients with structurally normal hearts: Does fibrosis type matter?
Gil, K. E., Mikrut, K., Mazur, J., Black, A. L., Truong, V. T., Smart, S., & Zaręba, K. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295519 · Cited by 8
Karadaş, H., Tosun, H., & Ceylan, H. (2024) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2670 · Cited by 8
Dilated cardiomyopathy: from genes and molecules to potential treatments
Wang, X., Lang, Z., Yan, Z., Xu, J., Zhang, J., Jiao, L., & Zhang, H. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05269-0 · Cited by 8
Ferro, A., Segreti, A., Crispino, S. P., Cricco, R., Cristo, A. D., Ciancio, M., Gurrieri, F., Ussia, G. P., & Grigioni, F. (2025) · Genes · doi:10.3390/genes16070801 · Cited by 8
Glazer, A. M., Tabet, D. R., Parikh, V. N., Kroncke, B. M., Coté, A. G., Yamamoto, Y., Wang, Q., Muhammad, A., Lancaster, M. C., O’Neill, M. J., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01201-7 · Cited by 8
Cho, E., Kang, H., Kang, D.-K., & Lee, Y. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005634 · Cited by 8
Genetic Factors Involved in Cardiomyopathies and in Cancer
Molina, M. S., Peñalver, M. N., Muñoz‐Esparza, C., Esteban-Gil, Á., Mateo, J. J. S., & Gimeno, J. R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061702 · Cited by 8
Lin, L., Liu, S., Chen, Z., Xia, Y., Xie, J., Fu, M., Lu, D., Wu, Y., Shen, H., Yang, P., et al. (2022) · Open Research (University of Surrey) · doi:10.1002/viw.20220040 · Cited by 8
Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
Gaar-Humphreys, K. R., van den Brink, A., Wekking, M., Asselbergs, F. W., van Steenbeek, F. G., Harakaľová, M., & Pei, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1114459 · Cited by 8
Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
Nomura, S., & Ōno, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1137498 · Cited by 8
Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
Wang, Y., Xie, Y., Mahara, G., Xiong, Y., Xiong, Y., Zheng, Q., Chen, J., Zhang, W., Zhou, H., & Li, Q. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04605-6 · Cited by 8
RNA binding proteins in cardiovascular development and disease
Verma, S. K., & Kuyumcu‐Martinez, M. N. (2024) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2024.01.007 · Cited by 8
Imaging Features of Arrhythmogenic Cardiomyopathies
Galizia, M. S., Attili, A. K., Truesdell, W. R., Smith, E. D., Helms, A. S., Sulaiman, A., Madamanchi, C., & Agarwal, P. (2024) · Radiographics · doi:10.1148/rg.230154 · Cited by 9
Genotype-Phenotype Insights of Inherited Cardiomyopathies—A Review
Voinescu, O. R., Ionac, A., Șoșdean, R., Ionac, I., Luca, S. A., Kundnani, N. R., Morariu, S., Puiu, M., & Chiriță-Emandi, A. (2024) · Medicina · doi:10.3390/medicina60040543 · Cited by 11
Exploring novel MYH7 gene variants using in silico analyses in Korean patients with cardiomyopathy
Kim, O.-H., Kim, J., Kim, Y. J., Lee, S., Lee, B. H., Kim, B.-J., Park, H., & Park, M. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-02000-8 · Cited by 8
Causes and consequences of DNA double-stranded breaks in cardiovascular disease
Marian, A. J. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05131-9 · Cited by 8
Sarcomere variants in arrhythmogenic cardiomyopathy: Pathogenic factor or bystander?
Chen, K., Rao, M., Guo, G., Chen, X., Chen, L., & Song, J. (2018) · Gene · doi:10.1016/j.gene.2018.10.080 · Cited by 8
Dilated cardiomyopathy caused by a pathogenic nucleotide variant in RBM20 in an Iranian family
Malakootian, M., Moghaddam, M. B., Kalayinia, S., Farrashi, M., Maleki, M., Sadeghipour, P., & Amin, A. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01262-4 · Cited by 8
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy
D’Agostino, Y., Palumbo, D., Rusciano, M. R., Strianese, O., Amabile, S., Rosa, D. D., Angelis, E. D., Visco, V., Russo, F., Alexandrova, E., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12102411 · Cited by 8
Ghasemi, S., Mahdavi, M., Maleki, M., Salahshourifar, I., & Kalayinia, S. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01388-5 · Cited by 8
Prognostic value of free triiodothyronine in patients with dilated cardiomyopathy
Zhao, H., Sun, L. V., Zhu, Y., Chen, Q.-S., Zhu, W., Toorabally, M. B., Chen, X., & Zhang, F. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000896 · Cited by 8
Genetic aspects of the oxidative phosphorylation dysfunction in dilated cardiomyopathy
Bayona‐Bafaluy, M. P., Iglesias, E., López‐Gallardo, E., Emperador, S., Pacheu‐Grau, D., Labarta, L., Montoya, J., & Ruiz‐Pesini, E. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108334 · Cited by 8
Li, B., Zhan, Y., Liang, Q., Xu, C., Zhou, X., Cai, H., Zheng, Y., Guo, Y., Wang, L., Qiu, W., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00843-w · Cited by 8
Cheng, N., Mo, Q., Donelson, J., Wang, L., Breton, G., Rodney, G. G., Wang, J., Hirschi, K. D., Wehrens, X. H. T., & Nakata, P. A. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60263 · Cited by 8
Katraki-Pavlou, S., Kastana, P., Bousis, D., Ντενέκου, Δ., Varela, A., Davos, C. H., Νίκου, Σ., Papadaki, E., Tsigkas, G., Athanasiadis, E. I., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00400.2021 · Cited by 8
Sinagra, G., Ferro, M. D., & Merlo, M. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.002004 · Cited by 8
Reappraising Genes for Dilated Cardiomyopathy: Stepping Back to Move Forward
OWENS, A. T., & Day, S. M. (2021) · Circulation · doi:10.1161/circulationaha.121.054961 · Cited by 8
Sheikh, M., Fallah, S. A., Moradi, M., Jalali, A., Vakili‐Basir, A., Sahebjam, M., Ashraf, H., & Zoroufian, A. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04355-3 · Cited by 7
RBM20 Truncating Variants and Human Cardiomyopathy
Floyd, B. J., Njoroge, J. N., Krysov, V. A., Gomes, B., Murtha, R., Aribeana, C. N., Cannie, D. E., Smith, E. D., Paldino, A., Brown, E. E., et al. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.0401 · Cited by 7
Self-citationTranscriptome studies of inherited dilated cardiomyopathies
Koslow, M., Mondaca‐Ruff, D., & Xu, X. (2023) · Mammalian Genome · doi:10.1007/s00335-023-09978-z · Cited by 7
Zhou, Y., Gao, S., Ding, L., Yan, H., Pang, S., & Yan, B. (2023) · DNA and Cell Biology · doi:10.1089/dna.2022.0525 · Cited by 7
Genetic profile and genotype–phenotype correlations in childhood cardiomyopathy
Wanert, C., Louali, F. E., Al-Dybiat, S., Nguyen, K., Zaffran, S., & Ovaert, C. (2023) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2023.04.008 · Cited by 7
Cardiomyopathy in Asian Cohorts: Genetic and Epigenetic Insights
Tan, K., Foo, R., & Loh, M. C. S. (2023) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.123.004079 · Cited by 8
Symptomatic presentation influences outcomes in pediatric restrictive cardiomyopathy
Lorenzo, M., Lynch, Á., Ashkanase, J., Fazari, L., George, K., Arathoon, K., Minn, S., Nicolson, D., Jeewa, A., & Jean-st-michel, E. M. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1264751 · Cited by 7
Solaro, R. J., Goldspink, P. H., & Wolska, B. M. (2024) · Biomedicines · doi:10.3390/biomedicines12050999 · Cited by 7
Moradi, A., Khoshniyat, S., Nzeako, T. R., Tabari, M. A. K., Olanisa, O. O., Tabbaa, K., Alkowati, H., Askarianfard, M., Daoud, D., Oyesanmi, O., et al. (2025) · Cureus · doi:10.7759/cureus.79372 · Cited by 7
Prognostic Significance of B-Type Natriuretic Peptide in Patients With Left Ventricular Thrombus
An, Z., Gao, Z., Wang, L., Hou, C., Zhang, L., Gong, S., Rao, R., Li, C., & Qin, Z. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.667908 · Cited by 7
BAG3 Genetic Cardiomyopathy May Overlap Fulminant Myocarditis Clinical Findings
Jordà, P., Martínez, D., Farrero, M., Marcos, M. Á., Sandoval, E., Castel, M. Á., Pereda, D., Quintana, E., Arbelo, E., Sánchez, A., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008443 · Cited by 7
Huang, W., Xu, R., Gao, N., Wu, X., & Wen, C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.822150 · Cited by 7
Guevara‐Ramírez, P., Cadena-Ullauri, S., Ibarra-Castillo, R., Laso-Bayas, J. L., Paz‐Cruz, E., Tamayo‐Trujillo, R., Ruiz‐Pozo, V. A., Doménech, N., Ibarra-Rodríguez, A. A., & Zambrano, A. K. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1141083 · Cited by 7
Furquim, S. R., Linnenkamp, B. D. W., Olivetti, N., Giugni, F., Lipari, L. F. V. P., Andrade, F. A., & Krieger, J. E. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230174 · Cited by 7
Kumar, S., Kumar, V., & Kim, J.-J. (2020) · Biomolecules · doi:10.3390/biom10030442 · Cited by 7
Pour-Ghaz, I., Heckle, M., Ifedili, I., Kayali, S., Nance, C., Kabra, R., Jha, S. K., Jefferies, J. L., & Levine, Y. C. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x17666210804125939 · Cited by 7
Genetic risk factors for dilated cardiomyopathy
Vaikhanskaya, T. G., Sivitskaya, L. N., Левданский, О. Д., Курушко, Т. В., & Даниленко, Н. Г. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4628 · Cited by 7
Metadata
- Authors
- McNally, E. M., & Mestroni, L.
- Affiliations
- Northwestern University (US)
- Venue
- Circulation Research
- Published
- 2017-09-15
- Volume
- 121
- Issue
- 7
- Pages
- 731-748
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC5626020
- OpenAlex
- W2755193453
- Cited by
- 786
- References
- 172
- Citations by year
- 2026: 63 · 2025: 89 · 2024: 93 · 2023: 123 · 2022: 89 · 2021: 105 · 2020: 95 · 2019: 79 · 2018: 43 · 2017: 4
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR001422, UL1TR001082)
- National Heart, Lung, and Blood Institute (R01HL122109, R01HL116906, R01HL147064, R01HL128075, R01HL061322, R01HL069071)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Keywords
- dilated cardiomyopathy, non-ischemic cardiomyopathy, genetic testing, gene panel, cascade testing, arrhythmia risk, prognosis, genetic variants, pathophysiological mechanisms, cardiac morphology, early intervention
- MeSH terms
- Animals, Biopsy, Cardiomyopathy, Dilated, DNA Mutational Analysis, Genetic Markers, Humans, Mutation, Myocardium, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, Ventricular Function, Risk Assessment, Genetic Predisposition to Disease, Molecular Diagnostic Techniques, Cardiac Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
